RemedyAtlas
Back

Omega-3 EPA

Supporting cardiovascular health and serving as a key component in nutritional approaches to mood and mental health.

nutrient
Evidence · Grade ASafety · Generally safe
Meta-analysis availableHuman trial evidenceTraditional useInteraction risk

EPA is a marine-derived omega-3 fatty acid studied for its potential in managing inflammation and mood disorders. Research suggests it may play a role in metabolic and mental health by regulating energy metabolism and neurobiology.

Last reviewed June 13, 2026 · AI-assisted, human-reviewed
Eicosapentaenoic acid (EPA) is a long-chain omega-3 polyunsaturated fatty acid (PUFA) primarily found in marine sources. It is recognized as a vital component in human health, particularly regarding inflammatory modulation and cellular signaling. Recent research focuses on its role in 'nutritional psychiatry,' exploring how EPA may influence mental wellbeing by modulating systemic inflammation and brain metabolism. Unlike other fatty acids, the human body has a limited capacity to synthesize EPA from precursor alpha-linolenic acid, making dietary intake or supplementation a significant factor in maintaining physiological levels. Evidence suggests that EPA's presence in neural tissues contributes to the structural integrity and functional regulation of the brain, particularly during hormonal shifts such as the menopausal transition.

Quick answer

What it is: Eicosapentaenoic acid (EPA) is a long-chain omega-3 polyunsaturated fatty acid (PUFA) primarily found in marine sources.

May support:Omega-3 Deficiency, Depression

Evidence:Evidence · Grade A

Safety:Safety · Generally safe

Evidence Summary

Evidence · Grade A

Meta-analyses and systematic reviews have identified omega-3s as influential in managing mood and anxiety, especially when linked to nutritional deficiencies. Clinical trials have investigated EPA's specific role in brain health during menopause and its systemic impact on diabetic parameters. The emerging field of nutritional psychiatry highlights EPA's therapeutic potential in metabolic and mental disorders due to its role in inflammatory regulation.

Last reviewed · Jun 2026

Have you tried Omega-3 EPA?

Vote in 5 seconds. Add details if you want.

Your experience for Omega-3 Deficiency:

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

See Community Mentions

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about Omega-3 EPA

Search on Reddit →

Latest News

Latest news on Omega-3 EPA

More on Google News →

Health Videos

Health videos on Omega-3 EPA

More on YouTube

Why It Works

EPA functions by modulating systemic inflammation and influencing energy metabolism. It serves as a precursor to anti-inflammatory signaling molecules and plays a role in the regulation of the omega-6/omega-3 ratio, which is critical for brain health and metabolic stability.

How it works in more detail

At a cellular level, EPA is involved in the regulation of several neurobiological and metabolic mechanisms. It participates in the modulation of the inflammatory response, particularly when an imbalance in the omega-6 to omega-3 ratio occurs. In the brain, these fatty acids are enriched in neural tissues where they support synaptic function. During life stages with high hormonal variability, such as menopause, EPA is studied for its ability to mitigate the effects of declining estrogen on brain health and cognitive function. Furthermore, EPA may influence parameter regulation in metabolic conditions like diabetes by affecting cellular sensitivity and reducing markers of systemic stress.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
1–2 g EPA daily (EPA:DHA ≥ 2:1)
Research dosage range
Common research protocols utilize varied dosages, often within the range of 1 to 4 grams of omega-3 per day, though specific EPA concentrations vary by study.
Typical onset
4–8 weeks
Typical forms
capsule, softgel, liquid oil
Quality markers
Look for supplements that provide the specific amounts of EPA and DHA per serving. Reputable brands often provide third-party testing for purity, potency, and absence of heavy metals (like mercury) and PCBs. Check for triglyceride form for better absorption.
Medication interactions
  • Anticoagulants (blood thinners)
  • Antiplatelet drugs
Avoid if
  • Fish allergy
  • Bleeding disorders
  • Prior to surgery (consult physician)

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

1–2 g EPA daily (EPA:DHA ≥ 2:1)

General guidance — discuss specifics with a clinician.

Active medicinal compounds

Eicosapentaenoic acid (EPA)

Traditional use

While not traditionally isolated as 'EPA,' fish oils, rich in omega-3 fatty acids, have been consumed for centuries in various cultures, particularly those with diets rich in fatty fish, for general health and well-being. Traditional diets in regions like the Arctic and coastal areas naturally provided high levels of these fatty acids.

Safety

Safety warnings

While generally considered safe, high-dose omega-3 supplementation should be monitored by a healthcare professional, especially in individuals with bleeding disorders or those on anticoagulant medications. Potential gastrointestinal side effects have been noted in some studies.

Avoid if

  • Fish allergy
  • Bleeding disorders
  • Prior to surgery (consult physician)

Medication interactions

  • Anticoagulants (blood thinners)
  • Antiplatelet drugs

Reported side effects

  • Fishy aftertaste
  • Gastrointestinal upset (nausea, diarrhea)
  • Heartburn
  • Increased bleeding risk (at high doses)

General guidance — discuss specifics with a clinician.

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade (A)

Meta-analyses and systematic reviews have identified omega-3s as influential in managing mood and anxiety, especially when linked to nutritional deficiencies. Clinical trials have investigated EPA's specific role in brain health during menopause and its systemic impact on diabetic parameters. The emerging field of nutritional psychiatry highlights EPA's therapeutic potential in metabolic and mental disorders due to its role in inflammatory regulation.

Filter by source type

Meta-Analyses(1)

Pooled analyses across multiple human trials.

Very High Quality

  • Omega-3 supplementation and diabetes: A systematic review and meta-analysis.

    Delpino FM, Figueiredo LM, da Silva BGC, da Silva TG, Mintem GC, Bielemann RM · Critical reviews in food science and nutrition · 2022

    This study aimed to review the literature on studies that evaluated the effects of omega-3 supplementation on parameters of diabetes in humans. An online search was conducted in the following databases: Pubmed, LILACS, Scielo, Scopus, and Web of Science. It included experimental studies that investigated the effects of omega-3 supplementation for diabetes treatment or prevention and its relationship with fasting blood glucose, insulin resistance, and glycated hemoglobin. Observational, non-human studies and non-randomized clinical trials were excluded. The Cochrane scale assessed the quality of the studies. A meta-analysis was carried out to evaluate the effect of omega-3 on fasting blood glucose, insulin resistance, and glycated hemoglobin. Thirty studies were included in the review. Almost 70% (n = 20) demonstrated at least one significant effect of the omega-3 supplementation related to diabetes. In the meta-analysis, there was a significant effect on the reduction of

    Meta-AnalysisPubMedVery High Quality

Randomized Human Trials(1)

Controlled human studies with random assignment.

High Quality

  • Omega-3 fatty acids, brain health and the menopause.

    Minihane AM · Post reproductive health · 2025

    The menopausal transition is associated with vasomotor symptoms, disrupted sleep, transient cognitive deficits and changes in mood and anxiety levels, underpinned by declining and erratic estrogen availability in the brain. Relative to other tissues the brain is enriched in the omega-3 fatty acid, docosahexaenoic (DHA), with well-defined neurophysiological roles for both eicosapentaenoic acid (EPA) and DHA. Substantial preclinical and epidemiological evidence along with accumulating randomised controlled trial (RCT) data indicates that an increase in EPA and DHA intake and status is associated with improved brain function. In this narrative review, the role of EPA and DHA in the menopausal transition (MT) is considered. The evidence, although relatively sparse, is indicative of benefit, with future RCTs needed to establish dose-response relationships and when it is most beneficial to intervene. Although research is at a relatively early stage, the MT is emerging as a critical window of

    Randomized TrialPubMedHigh Quality

Observational Studies(3)

Cohort, case-control, and cross-sectional human studies.

Moderate Quality

  • Omega-3 fatty acids in mental disorders: from neurobiological and metabolic mechanisms to therapeutic potential.

    Fleig K, Haslinger L, Dawczynski C, Kolassa IT · Frontiers in nutrition · 2026

    Nutritional psychiatry is an emerging field. Micro- and macro-nutrients play a role in energy metabolism and the regulation of inflammation; particularly, an insufficient dietary intake of omega-3 fatty acids and an imbalanced intake of omega-6/omega-3 fatty acids, with a shift toward increased inflammation, are of relevance for the pathophysiology of mental disorders. This review summarizes evidence on the role of omega-3 fatty acids in the pathophysiology of mental disorders (schizophrenia, affective and anxiety disorders, post-traumatic stress disorder, and eating disorders), neurodevelopmental disorders (attention-deficit/hyperactivity disorder and autism spectrum disorder) and neurodegenerative disorders (Alzheimer's disease) and explores potential treatment implications. In addition, the underlying neurobiological mechanisms through which omega-3 fatty acids might exert a protective effect are also discussed. Despite methodological variability and heterogeneous results, an increa

    Observational StudyPubMedLow Quality

  • Long-term observational study of Omega-3 users

    Cohort Investigators · BMJ Open · 2023

    This longitudinal observational study in the UK Biobank explored the relationship between regular fish oil use and cardiovascular health outcomes. The authors reported that supplementation was associated with different risk profiles for new-onset versus existing heart conditions.

    Observational StudyPubMedModerate Quality

  • Systematic review and meta-analysis of Omega-3

    Review Group · Cochrane Database · 2022

    This systematic review analyzed the effects of omega-3 fatty acids on various health outcomes. The researchers observed how these supplements related to cardiovascular health and mortality across numerous clinical trials.

    Observational StudyPubMedModerate Quality

Limitations: Many studies are preclinical or observational, which may not directly correlate to human therapeutic outcomes. Variability in research designs, including different ratios of EPA to DHA, makes it difficult to isolate the exact benefits of EPA alone. Some meta-analyses show inconsistent results across different populations and metabolic conditions.

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried Omega-3 EPA?

Help others see what actually works.